Emerging fungal threats from the environment-a lesson from Candida auris and a warning about a second candidate, Rhodosporidiobolus fluvialis. [PDF]
Choi Y, Heitman J, Won EJ.
europepmc +1 more source
Wastewater intelligence predicts the emergence of clinically-relevant and drug-resistant Candidozyma auris at healthcare facilities. [PDF]
Chang CL +18 more
europepmc +1 more source
F2F-202, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor, Behaves as an Arrow with Multiple Tips against Azole-Resistant <i>C. albicans</i>: Modulation of Yeast-to-Hyphae Transition, Trailing Effect, and Oxidative Stress. [PDF]
Barone S +8 more
europepmc +1 more source
In vitro activity of eight antifungal drugs against clinical and hospital isolates of Candida parapsilosis complex; a multicenter study, 2023-2024. [PDF]
Moslemi A +13 more
europepmc +1 more source
Susceptibility of Candida auris isolates to antifungal agents: perspectives from whole-genome sequencing and phenotypic testing. [PDF]
Xie Z, Li Y, Yang F, Liu W, Cai R, Lu Y.
europepmc +1 more source
Genomic insights into a clade-specific <i>Candida tropicalis</i> lineage with resistance to azoles and immune evasion traits. [PDF]
Jain K +16 more
europepmc +1 more source
Inhibition of Candida albicans yeast-to-hypha transition and virulence by cyclic dipeptides derived from probiotic Aeromonas veronii V03. [PDF]
Sekar J +5 more
europepmc +1 more source
Genomic Characterization of Candida spp. Highlights a Persistent, Azole-Resistant C. parapsilosis Clone Circulating in a Tertiary Care Hospital During the First COVID-19 Wave. [PDF]
Vumbaca M +9 more
europepmc +1 more source
Non-albicans Candida in Vulvovaginal Candidiasis: Antifungal Resistance and Expression of ERG11, CDR1, CDR2, and MDR1 Genes. [PDF]
Ranjbar Golafshani FZ +3 more
europepmc +1 more source
First draft genome sequence of <i>Candidozyma auris</i> from a human clinical isolate in a major metropolitan hospital in Lima, Peru. [PDF]
Cuicapuza D +3 more
europepmc +1 more source

